Hemophilia Mobile App Usability Pilot

NAUnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 22, 2017

Primary Completion Date

May 11, 2018

Study Completion Date

May 11, 2018

Conditions
Hemophilia
Interventions
DEVICE

SureSource Engage application

"Eligible patients who choose to participate in the study will be asked to wear an actigraphy device \[ActiGraph GT9X Link Actigraph Link\] on their wrist continuously during both 4-week study phases.~The ActiGraph Link is a small (3.5 X 3.5 X 1 cm) wristwatch like device weighing approximately 14 grams that measures indicators of the wearer's activity and sleep patterns, including: acceleration, energy expenditure, steps, basal metabolic rate, activity intensity, sleep time, sleep efficiency, sleep latency, and body position.~The application being utilized is SureSource Engage application from Clinical Ink. The application is compatible to most Android and iOS devices.~Participants will also use a basic Bluetooth-enabled weight scale that syncs with the application."

Trial Locations (1)

10032

Healthcare Innovation and Technology Lab, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Healthcare Innovation Technology Lab

INDUSTRY